Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SBFMW

Sunshine Biopharma (SBFMW)

Sunshine Biopharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SBFMW
일자시간출처헤드라인심볼기업
2024/06/1205:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/06/0805:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/2305:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/2104:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMWSunshine Biopharma Inc
2024/05/1523:40Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/0905:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2024/05/0701:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
2023/12/0422:30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMWSunshine Biopharma Inc
2023/08/1121:30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1622:58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1221:00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2023/05/1122:00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMWSunshine Biopharma Inc
2023/04/0521:00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMWSunshine Biopharma Inc
2023/02/2821:30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMWSunshine Biopharma Inc
2023/02/1021:35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMWSunshine Biopharma Inc
2023/01/1921:30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMWSunshine Biopharma Inc
2022/12/2022:00GlobeNewswire Inc.Sunshine Biopharma’s Annual Letter to ShareholdersNASDAQ:SBFMWSunshine Biopharma Inc
2022/11/1622:00GlobeNewswire Inc.Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA ProjectNASDAQ:SBFMWSunshine Biopharma Inc
2022/10/2021:00GlobeNewswire Inc.Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueNASDAQ:SBFMWSunshine Biopharma Inc
2022/08/0421:00GlobeNewswire Inc.Sunshine Biopharma Files Its Second Quarter Report With the SECNASDAQ:SBFMWSunshine Biopharma Inc
2022/07/2821:10GlobeNewswire Inc.Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2905:50GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2613:41GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/2521:00GlobeNewswire Inc.Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
2022/04/0521:00GlobeNewswire Inc.Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
2022/03/1507:12GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/03/1023:17GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
2022/02/2600:20InvestorsHub NewsWireSUNSHINE BIOPHARMA EXPANDS ANTI-CORONAVIRUS DRUG DEVELOPMENT PROGRAM BY SIGNING A COLLABORATION AGREEMENT WITH THE UNIVERSITY OF ARIZONANASDAQ:SBFMWSunshine Biopharma Inc
2022/02/2522:00GlobeNewswire Inc.Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
2022/02/1800:07GlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:SBFMWSunshine Biopharma Inc
 검색 관련기사 보기:NASDAQ:SBFMW